Cancer News and Research

Latest Cancer News and Research

UV induction of melanin is directly involved in melanoma formation

A new study conducted by GW School of Medicine and Health Sciences (SMHS) researchers Edward C. De Fabo, Ph.D., Frances P. Noonan, Ph.D., and Anastas Popratiloff, M.D., Ph.D., has been published in the journal Nature Communications. Their paper, entitled "Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment," was published in June 2012.

24 Jul 2012

Study reveals 50% increased risk of urothelial and colorectal cancers in adulthood

Parents are increasingly conscious of the dangers of childhood obesity. There is a growing recognition of health problems associated with extra pounds, including the risk of diabetes, heart disease, and joint and muscle pain.

24 Jul 2012

PAMAM G-3 actually prevents activation of the process that leads to thrombosis

A compound that mops up debris of damaged cells from the bloodstream may be the first in a new class of drugs designed to address one of medicine's most difficult challenges -- stopping the formation of blood clots without triggering equally threatening bleeding.

24 Jul 2012

Roundup: Plan for new Md. hospital advances; Outsourcing of prison health care gets scrutiny; Alaska Native medical center seen as model

Maryland officials are preparing to unveil this week a detailed plan for a $600 million regional hospital to replace the ailing Prince George's Hospital Center and establish a new health-care network throughout Prince George's County. The plans are part of a broad effort to improve health care in a county where an estimated 150,000 residents lack health insurance or have insufficient coverage and often rely on hospital emergency rooms for primary care.

24 Jul 2012

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that the first of two canine oncology products has received approval by regulators in both the U.S. and Canada.

24 Jul 2012

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.

24 Jul 2012

Neural precursor cells suppress aggressive tumors

Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors.

23 Jul 2012

Synthetic triterpenoids block development of Parkinson's disease

A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.

23 Jul 2012

Third-party groups to target health law with new wave of attack ads

Also in the news, the Supreme Court -- especially after the recent health law decision -- is an effective tool to rally fundraising among both Democrats and Republicans. Meanwhile, a defense policy expert suggests presidential candidates focus on long-term military mental health issues. Finally, The Wall Street Journal examines how health care is playing in the Montana Senate race, where candidates are sparring over who is soft on cancer.

23 Jul 2012

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

HALO Healthcare, Inc., a provider of innovative diagnostic solutions for women's breast care announced that it has signed a definitive license agreement with the University of North Dakota (UND) to develop biomarkers for the early detection of breast cancer.

23 Jul 2012

Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia

Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."

23 Jul 2012

Novel genomic sequencing method can help conduct in-depth analysis of single cells

Only by viewing a Georges Seurat painting at close range can you appreciate the hidden complexities of pointillism - small, distinct dots of color applied to form an image from a distance. Similarly, biologists and geneticists have long sought to analyze profiles of genes at the single cell level but technology limitations have only allowed a view from afar.

23 Jul 2012

Cerulean commences dosing in CRLX101 Phase 2 study for ovarian cancer

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.

23 Jul 2012

SUMEC to distribute Aurora's breast MRI technology in China

Aurora Imaging Technology, Inc. is pleased to announce an exclusive China distribution agreement with the SUMEC Group Corporation.

23 Jul 2012

NSCLC survival increase 'an artifact of PET assessment'

There has been no increase in survival among non-small-cell lung cancer patients in recent years, with evidence suggesting otherwise likely due to positron emission tomography-induced stage migration and selection bias, say US scientists.

23 Jul 2012

Fat grafts ‘safe’ following breast reconstruction

Autologous fat grafting following breast reconstruction does not increase the long-term risk for tumor recurrence, US research shows.

23 Jul 2012

First Edition: July 23, 2012

In this Kaiser Health News video, Greg Millett, a senior policy advisor in the Office of National AIDS Policy, tells Joanne Silberner that the president's National HIV/AIDS Strategy has improved coordination among federal agencies and that the 2010 health law will improve access to care for those living with HIV/AIDS.

23 Jul 2012

Computer program based on GLDM can improve accuracy in diagnosis of prostate cancer

Scientists in France have developed a computer program that can analyse in detail different shades of grey in medical images. Writing in a recent issue of the International Journal of Signal and Imaging Systems Engineering, they explain how the program based on the Grey Level Diﬀerence Method can improve accuracy in the diagnosis of prostate cancer.

23 Jul 2012

Researchers uncover protein structure that regulates blood cell formation and activity

A Finnish research team together with researchers from New York, USA, has uncovered a protein structure that regulates cell signalling and the formation of blood cells. The team's results, published in Nature Structural & Molecular Biology, the most prestigious journal in the field, shed light on the mechanisms at play in haematological disorders and provide new opportunities for the design of disease-specific treatment.

23 Jul 2012

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical Research Institute (FFBCRI) formerly known as the National Neurovision Research Institute (NNRI).

23 Jul 2012

Cancer News and Research

Latest Cancer News and Research

UV induction of melanin is directly involved in melanoma formation

Study reveals 50% increased risk of urothelial and colorectal cancers in adulthood

PAMAM G-3 actually prevents activation of the process that leads to thrombosis

Roundup: Plan for new Md. hospital advances; Outsourcing of prison health care gets scrutiny; Alaska Native medical center seen as model

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Neural precursor cells suppress aggressive tumors

Synthetic triterpenoids block development of Parkinson's disease

Third-party groups to target health law with new wave of attack ads

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia

Novel genomic sequencing method can help conduct in-depth analysis of single cells

Cerulean commences dosing in CRLX101 Phase 2 study for ovarian cancer

SUMEC to distribute Aurora's breast MRI technology in China

NSCLC survival increase 'an artifact of PET assessment'

Fat grafts ‘safe’ following breast reconstruction

First Edition: July 23, 2012

Computer program based on GLDM can improve accuracy in diagnosis of prostate cancer

Researchers uncover protein structure that regulates blood cell formation and activity

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in